Platelet-monocyte aggregates in patients with chronic venous insufficiency remain elevated following correction of reflux

Cardiovascular Surgery

Volumn 10, Issue 5, 2002, Pages 464-469

  Rohrer, Michael J ^a   Claytor, R Brannon ^a   Garnette, Charles S C ^a   Powell, Craig C ^a   Barnard, Marc R ^a   Furman, Mark I ^a   Michelson, Alan D ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Leukocyte; Monocyte; Platelet; Ulceration; Venous stasis

Indexed keywords

ADENOSINE DIPHOSPHATE; BUFFER;

ADULT; ARTICLE; BLOOD ANALYSIS; CHRONIC VEIN INSUFFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LEG VEIN; MALE; MONOCYTE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME; VEIN STRIPPING; VENOUS BLOOD; VENOUS REFLUX;

ADULT; CELL AGGREGATION; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PLATELET AGGREGATION; POSTOPERATIVE PERIOD; VARICOSE VEINS; VENOUS INSUFFICIENCY;

EID: 0036789904     PISSN: 09672109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-2109(02)00049-2     Document Type: Article

References (23)

1. Browse N.L., Burnand K.G. The cause of venous ulceration. Lancet. 2:1982;243-245.
2. Coleridge Smith P.D., Thomas P., Scurr J.H., et al. Causes of venous ulceration: a new hypothesis. Br Med J (Clin Res Ed). 296:1988;1726-1727.
3. Thomas P.R., Nash G.B., Dormandy J.A. White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J (Clin Res Ed). 296:1988;1693-1695.
4. Smith P.D. Neutrophil activation and mediators of inflammation in chronic venous insufficiency. J Vasc Res. 36:(1):1999;24-36.
5. Saharay M., Shields D.A., Porter J.B., et al. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg. 26:1997;265-273.
6. Pappas P.J., Fallek S.R., Garcia A., et al. Role of leukocyte activation in patients with venous stasis ulcers. J Surg Res. 59:1995;553-559.
7. Powell C.C., Rohrer M.J., Barnard M.R., et al. Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation. J Vasc Surg. 30:1999;844-851.
8. Peyton B.D., Rohrer M.J., Furman M. I, et al. Patients with venous stasis ulceration have increased monocyte-platelet aggregation. J Vasc Surg. 27:1998;1109-1115.
9. Goodfield M.J. A relative thrombocytosis and elevated mean platelet volume are features of gravitational disease. Br J Dermatol. 115:1986;521-528.
10. Moyses C., Cederholm-Williams S.A., Michel C.C. Haemoconcentration and accumulation of white cells in the feet during venous stasis. Int J Microcirc Clin Exp. 5:1987;311-320.
11. Celi A., Lorenzet R., Furie B., et al. Platelet-leukocyte-endothelial cell interaction on the blood vessel wall. Semin Hematol. 34:1997;327-335.
12. Larsen E., Celi A., Gilbert G.E., et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 59:1989;305-312.
13. Porter J.M., Moneta G.L. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg. 21:1995;635-645.
14. Rutherford R.B., Padberg F.T. Jr., Comerota A.J., et al. Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg. 31:2000;1307-1312.
15. Wilkinson L.S., Bunker C., Edwards J.C., et al. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg. 17:1993;669-675.
16. Schmid-Schonbein G.W. The damaging potential of leukocyte activation in the microcirculation. Angiology. 44:1993;45-56.
17. Ono T., Bergan J.J., Schmid-Schonbein G.W., et al. Monocyte infiltration into venous valves. J Vasc Surg. 27:1998;158-166.
18. Takase S., Schmid-Schonbein G., Bergan J.J. Leukocyte activation in patients with venous insufficiency. J Vasc Surg. 30:1999;148-156.
19. McMullin G.M., Watkin G.T., Coleridge Smith P.D., et al. Efficacy of fibrinolytic enhancement with stanozolol in the treatment of venous insufficiency. Aust N Z J Surg. 61:1991;306-309.
20. Shoab S.S., Porter J., Scurr J.H., et al. Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease-a prospective study. Eur J Vasc Endovasc Surg. 17:1999;313-318.
21. Shoab S.S., Porter J.B., Scurr J.H., et al. Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: a pilot study. J Vasc Surg. 31:2000;456-461.
22. Bergan J.J., Schmid-Schonbein G.W., Takase S. Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500 mg. Angiology. 52:(1):2001;S43-S47.
23. Guilhou J.J., Fevrier F., Debure C., Dubeaux D., et al. Benefit of a 2 month treatment with a micronized, purified flavonoidic fraction on venous ulcer healing. A randomized, double-blind, controlled vs placebo trial. Int J Microcirc Clin Exp. 17:(1):1997;21-26.